Paper

Plain Language Summary of the Manuscript: Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomised, double-blind, placebo-controlled phase 3 trial

Boehringer Ingelheim · 2026 · Lee M Kaplan, Elena Startseva, Carel Wynand le Roux et al.